{
    "id": "07ded955-cc21-4364-9869-e1f3f94b980a",
    "indications": "zaltrap , combination fluorouracil , leucovorin , irinotecan- ( folfiri ) , indicated treatment patients metastatic colorectal cancer ( mcrc ) resistant progressed following oxaliplatin-containing regimen .",
    "contraindications": "4 mg per kg intravenous infusion 1 hour every 2 weeks . ( 2.1 , 2.3 ) administer intravenous push bolus . ( 2.3 )",
    "warningsAndPrecautions": "zaltrap ( ziv-aflibercept ) injection clear , colorless pale-yellow solution supplied single-dose vials concentration 25 mg/ml . ndc 0024-5840-01 : carton containing one single-dose vial 100 mg/4 ml ( 25 mg/ml ) ndc 0024-5841-01 : carton containing one single-dose vial 200 mg/8 ml ( 25 mg/ml )",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "AFLIBERCEPT",
            "code": "15C2VL427D"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "POLYSORBATE 20",
            "code": "7T1F30V5YH"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE",
            "code": "70WT22SF4B"
        },
        {
            "name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
            "code": "593YOG76RN"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "organization": "sanofi-aventis  U.S. LLC",
    "name": "ZALTRAP",
    "effectiveTime": "20250521",
    "indications_original": "ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.",
    "contraindications_original": "4 mg per kg as an intravenous infusion over 1 hour every 2 weeks. ( 2.1 , 2.3 ) Do not administer as an intravenous push or bolus. ( 2.3 )",
    "warningsAndPrecautions_original": "ZALTRAP (ziv-aflibercept) injection is a clear, colorless to pale-yellow solution supplied in single-dose vials with a concentration of 25 mg/mL.\n                  NDC 0024-5840-01: carton containing one single-dose vial of 100 mg/4 mL (25 mg/mL)\n                  NDC 0024-5841-01: carton containing one single-dose vial of 200 mg/8 mL (25 mg/mL)",
    "adverseReactions_original": "None."
}